Livia Eiselleova

Title: Livia Eiselleova: Innovator in Cell Biology and Regenerative Medicine

Introduction

Livia Eiselleova is a prominent inventor based in Mocenok, Slovakia. She has made significant contributions to the field of cell biology and regenerative medicine through her innovative research and inventions. Her work focuses on developing novel polypeptides that have practical applications in medical and cosmetic fields.

Latest Patents

Livia holds a patent for a thermostable FGF2 polypeptide, which is an isolated polypeptide possessing FGF2 activity. This polypeptide has at least 85% sequence identity to SEQ ID NO: 2 (FGF2 wt) or a functional fragment thereof, and includes at least one amino acid substitution R31L. The invention is particularly useful in cell biology research, regenerative medicine, and related medical applications or cosmetics. Additionally, it discloses a culture medium comprising subjected FGF2 suitable for culturing human pluripotent stem cells, including both human embryonic stem cells and induced pluripotent stem cells.

Career Highlights

Throughout her career, Livia has worked with notable organizations, including Enantis S.r.o. and Masarykova Univerzita. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community significantly.

Collaborations

Livia has collaborated with several talented individuals, including Lukas Balek and Radka Chaloupkova. These collaborations have enriched her research and fostered innovation in her field.

Conclusion

Livia Eiselleova is a remarkable inventor whose work in developing thermostable polypeptides has the potential to impact various fields, including medicine and cosmetics. Her contributions to cell biology and regenerative medicine highlight her dedication to advancing scientific knowledge and innovation.